These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31435916)

  • 21. Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).
    Deer T; Rauck RL; Kim P; Saulino MF; Wallace M; Grigsby EJ; Huang IZ; Mori F; Vanhove GF; McDowell GC
    Pain Pract; 2018 Feb; 18(2):230-238. PubMed ID: 28449352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spasticity and the use of intrathecal baclofen in patients with spinal cord injury.
    Khurana SR; Garg DS
    Phys Med Rehabil Clin N Am; 2014 Aug; 25(3):655-69, ix. PubMed ID: 25064793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scoliosis, spinal fusion, and intrathecal baclofen pump implantation.
    Scannell B; Yaszay B
    Phys Med Rehabil Clin N Am; 2015 Feb; 26(1):79-88. PubMed ID: 25479781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term intrathecal drug administration for chronic nonmalignant pain.
    Duarte RV; Raphael JH; Sparkes E; Southall JL; LeMarchand K; Ashford RL
    J Neurosurg Anesthesiol; 2012 Jan; 24(1):63-70. PubMed ID: 21904220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spasticity in a child with myelomeningocele treated with continuous intrathecal baclofen.
    Bergenheim AT; Wendelius M; Shahidi S; Larsson E
    Pediatr Neurosurg; 2003 Oct; 39(4):218-21. PubMed ID: 12944705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does pain relief influence recovery of consciousness? A case report of a patient treated with ziconotide.
    Lanzillo B; Loreto V; Calabrese C; Estraneo A; Moretta P; Trojano L
    Eur J Phys Rehabil Med; 2016 Apr; 52(2):263-6. PubMed ID: 25491316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A safety review of approved intrathecal analgesics for chronic pain management.
    Chalil A; Staudt MD; Harland TA; Leimer EM; Bhullar R; Argoff CE
    Expert Opin Drug Saf; 2021 Apr; 20(4):439-451. PubMed ID: 33583318
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal Drug Delivery Systems for Noncancer Pain: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(2):1-77. PubMed ID: 27026797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intrathecal baclofen for children with chronic pain related to severe spasticity: advantages of tunneling the catheter in the testing phase].
    Gómez-Hoz T; Reinoso-Barbero F; de Vicente JC; Duran P; Campo G; Castro LE
    Rev Esp Anestesiol Reanim; 2005; 52(7):395-400. PubMed ID: 16200919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Dose Intrathecal Ziconotide for Spasticity From Primary Lateral Sclerosis: A Case Report.
    Zhu X; Kohan LR; Goldstein RB
    A A Pract; 2019 Jul; 13(1):31-33. PubMed ID: 31260413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients.
    Bolash R; Udeh B; Saweris Y; Guirguis M; Dalton JE; Makarova N; Mekhail N
    Neuromodulation; 2015 Feb; 18(2):150-5; discussion 155-6. PubMed ID: 25250852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

  • 35. Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.
    Sanford M
    CNS Drugs; 2013 Nov; 27(11):989-1002. PubMed ID: 23999971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal baclofen for spasticity management in Rett syndrome.
    Kadyan V; Clairmont AC; George RJ; Johnson EW
    Am J Phys Med Rehabil; 2003 Jul; 82(7):560-2. PubMed ID: 12819544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal baclofen for spasticity caused by thrombotic stroke.
    Gwartz BL
    Am J Phys Med Rehabil; 2001 May; 80(5):383-7. PubMed ID: 11327562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of increase in spasticity in patients with intrathecal baclofen pumps].
    Roche N; Even-Schneider A; Bussel B; Bensmail D
    Ann Readapt Med Phys; 2007 Mar; 50(2):93-9. PubMed ID: 17098318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal Drug Delivery Systems for Cancer Pain Control: Insights on Current Contemporary Practices in the US.
    Goel V; Kumar V; Blaes A; Gulati A
    Neuromodulation; 2023 Aug; 26(6):1256-1262. PubMed ID: 37318432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study.
    Middleton JW; Siddall PJ; Walker S; Molloy AR; Rutkowski SB
    Arch Phys Med Rehabil; 1996 Aug; 77(8):824-6. PubMed ID: 8702379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.